GM-CSF as Adjuvant Therapy of Melanoma

Clinical trial NCT00350597 · COMPLETED

Trial details

NCT number: NCT00350597
Sponsor: Northern California Melanoma Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2004-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.